Innovative Eyewear, Inc. (LUCY)
USD 5.55
(-7.65%)
USD 5.55
(-7.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.57 Million USD | -22.12% |
| 2022 | -5.54 Million USD | -73.39% |
| 2021 | -3.19 Million USD | -391.99% |
| 2020 | -762.22 Thousand USD | -493.91% |
| 2019 | -109.42 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.92 Million USD | 2.02% |
| 2024 Q1 | -657 Thousand USD | 18.22% |
| 2023 Q4 | -2.47 Million USD | -61.65% |
| 2023 FY | - USD | -22.12% |
| 2023 Q3 | -1.53 Million USD | -21.95% |
| 2023 Q2 | -1.25 Million USD | 11.07% |
| 2023 Q1 | -1.41 Million USD | 24.06% |
| 2022 Q2 | -1.14 Million USD | 3.46% |
| 2022 Q1 | -1.18 Million USD | 14.16% |
| 2022 FY | - USD | -73.39% |
| 2022 Q4 | -1.86 Million USD | -36.89% |
| 2022 Q3 | -1.35 Million USD | -18.99% |
| 2021 Q1 | -212.52 Thousand USD | -3.11% |
| 2021 FY | - USD | -391.99% |
| 2021 Q2 | -518.15 Thousand USD | -143.81% |
| 2021 Q4 | -1.37 Million USD | -26.61% |
| 2021 Q3 | -1.08 Million USD | -110.08% |
| 2020 Q2 | -56.16 Thousand USD | 0.0% |
| 2020 FY | - USD | -493.91% |
| 2020 Q4 | -206.1 Thousand USD | 0.0% |
| 2020 Q3 | - USD | 100.0% |
| 2020 Q1 | -56.16 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 85.591% |
| AngioDynamics, Inc. | -14.29 Million USD | 53.994% |
| AtriCure, Inc. | -8.1 Million USD | 18.916% |
| Avinger, Inc. | -16.34 Million USD | 59.775% |
| Azenta, Inc. | 55.15 Million USD | 111.922% |
| BioLife Solutions, Inc. | -45.23 Million USD | 85.465% |
| The Cooper Companies, Inc. | 882.8 Million USD | 100.745% |
| Daxor Corporation | 329.74 Thousand USD | 2094.036% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 50.181% |
| Femasys Inc. | -13.16 Million USD | 50.073% |
| GlucoTrack, Inc. | -7.09 Million USD | 7.275% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 169.263% |
| Hologic, Inc. | 1.29 Billion USD | 100.507% |
| ICU Medical, Inc. | 307.69 Million USD | 102.137% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.275% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 30.049% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 113.421% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -0.0% |
| Masimo Corporation | 236.7 Million USD | 102.778% |
| Microbot Medical Inc. | -10.63 Million USD | 38.169% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 141.692% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 102.841% |
| Nephros, Inc. | -1.37 Million USD | -376.805% |
| NovoCure Limited | -175.86 Million USD | 96.261% |
| NEXGEL, Inc. | -2.73 Million USD | -140.847% |
| NEXGEL, Inc. | -2.73 Million USD | -140.847% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 92.398% |
| OraSure Technologies, Inc. | 76.15 Million USD | 108.634% |
| Pro-Dex, Inc. | 8.33 Million USD | 178.905% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 84.481% |
| Predictive Oncology Inc. | -13.18 Million USD | 50.12% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -161.754% |
| QuidelOrtho Corporation | 545.6 Million USD | 101.205% |
| Repligen Corporation | 124.29 Million USD | 105.29% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -2174.37% |
| STAAR Surgical Company | 33.22 Million USD | 119.792% |
| Sharps Technology, Inc. | -8.98 Million USD | 26.783% |
| Utah Medical Products, Inc. | 24.8 Million USD | 126.507% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 102.834% |
| Jin Medical International Ltd. | 3.44 Million USD | 290.977% |